Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland

The objective of this study was to investig...

Source: BMC Ophthalmology - December 4, 2017 Category: Opthalmology Authors: Oliver Reich, Martin K. Schmid, Roland Rapold, Lucas M. Bachmann and Eva Blozik Tags: Research article Source Type: research